Form D — General Oncology, Inc.

0001658021-26-000006 · filed Apr 23, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry: Pharmaceuticals
Exemptions: 06b
Reported offering amount: $4,805,299
Reported amount sold: $4,805,299
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: General Oncology, Inc.
CIK: 1658021
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 57 Chapel Street, Third Floor
Newton, MA 02458
Phone: 617-468-4646

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Jeffrey Aaron Glazier · Executive Officer

Newton, MA Find on LinkedIn ↗
Arnold Glazier · Executive Officer

Newton, MA Find on LinkedIn ↗
Abid Ansari · Executive Officer

Newton, MA Find on LinkedIn ↗
Michael J. Petit · Director

Newton, MA Find on LinkedIn ↗
Barry Seeman · Director

Newton, MA Find on LinkedIn ↗

Other filings from this issuer

Form D — Jul 2, 2025 — 0001658021-25-000002

View the original filing on SEC EDGAR ↗